Story perspectives
NHS Launches Genetic Testing for Minority Cancer Patients
4/13/2026
1 of 1
Story summary
- The National Health Service (NHS) in England will offer new genetic testing to minority cancer patients.
- The testing aims to improve chemotherapy outcomes for Black and minority ethnic patients facing higher risks.
- The program adds testing for a fifth DPYD gene variant common among these groups.
- Experts say diverse representation in medical research is needed to ensure equitable care.
- The initiative advances ethnic health equity in cancer care.
